Trials / Sponsors / Frequency Therapeutics
Frequency Therapeutics
Industry · 7 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | First in Human Safety Study of FX-345 in Adults With Sensorineural Hearing Loss Hearing Loss, Sensorineural | Phase 1 | 2022-12-15 |
| Completed | FX-322 in Adults With Acquired Sensorineural Hearing Loss Hearing Loss, Sensorineural, Noise Induced Hearing Loss, Sudden Hearing Loss | Phase 2 | 2021-10-12 |
| Completed | FX-322 in Adults With Severe Sensorineural Hearing Loss Hearing Loss, Sensorineural, Noise Induced Hearing Loss, Sudden Hearing Loss | Phase 1 | 2020-11-02 |
| Completed | FX-322 in Adults With Age-Related Sensorineural Hearing Loss Presbycusis, Hearing Loss, Sensorineural, Noise Induced Hearing Loss | Phase 1 | 2020-09-17 |
| Completed | FX-322 in Adults With Stable Sensorineural Hearing Loss Sensorineural Hearing Loss, Noise Induced Hearing Loss, Sudden Sensorineural Hearing Loss | Phase 2 | 2019-10-04 |
| Completed | FX-322 in Sensorineural Hearing Loss Sensorineural Hearing Loss | Phase 1 / Phase 2 | 2018-07-03 |
| Completed | First in Human Safety Study of FX-322 in Adults Undergoing Cochlear Implantation Hearing Loss | EARLY_Phase 1 | 2017-05-30 |